Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SM03 plus methotrexate in rheumatoid arthritis
CTR20140856Phase 2Completed
- Sponsor
- Longrui Pharmaceutical
- Start
- Jan 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of suciraslimab in rheumatoid arthritis (RA), sponsored by Longrui Pharmaceutical. Started Jan 2015; status: completed.
02
Drugs
suciraslimab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20140856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140856.